Amphastar Pharmaceuticals, Inc.
AMPH
$27.09
-$0.49-1.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.35M | 31.03M | 25.29M | 37.96M | 40.43M |
| Total Depreciation and Amortization | 15.77M | 16.24M | 15.21M | 14.66M | 14.43M |
| Total Amortization of Deferred Charges | 885.00K | 842.00K | 762.00K | 724.00K | 744.00K |
| Total Other Non-Cash Items | 6.58M | 6.01M | 10.54M | -15.74M | 11.68M |
| Change in Net Operating Assets | 12.00M | -18.53M | -16.71M | -8.59M | -7.33M |
| Cash from Operations | 52.58M | 35.59M | 35.08M | 29.02M | 59.96M |
| Capital Expenditure | -5.35M | -10.57M | -10.70M | -12.41M | -13.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.27M | 9.94M | 21.18M | -23.27M | -20.79M |
| Cash from Investing | -19.62M | -625.00K | 10.48M | -35.68M | -34.59M |
| Total Debt Issued | 172.00K | 4.13M | 1.64M | 4.87M | 9.51M |
| Total Debt Repaid | -44.00K | -37.00K | -38.00K | -115.00K | -41.00K |
| Issuance of Common Stock | 379.00K | 494.00K | -- | -- | -- |
| Repurchase of Common Stock | -4.85M | -34.54M | -15.69M | -38.62M | -31.70M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.00K | -253.00K | -422.00K | 22.00K | -587.00K |
| Cash from Financing | -4.35M | -30.20M | -14.50M | -33.84M | -22.82M |
| Foreign Exchange rate Adjustments | -41.00K | 142.00K | 118.00K | -11.00K | -63.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.58M | 4.91M | 31.17M | -40.51M | 2.50M |